Neuroblastoma-Derived Sulfhydryl Oxidase, a New Member of the Sulfhydryl Oxidase/Quiescin6 Family, Regulates Sensitization to Interferon γ-Induced Cell Death in Human Neuroblastoma Cells

Cancer Research

Volumn 63, Issue 22, 2003, Pages 7742-7752

  Wittke, Isabel ^a   Wiedemeyer, Ruprecht ^a   Pillmann, Andrea ^a   Savelyeva, Larissa ^a   Westermann, Frank ^a   Schwab, Manfred ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GAMMA INTERFERON; NEUROBLASTOMA DERIVED SULFHYDRYL OXIDASE; PROTEIN DISULFIDE ISOMERASE; RESERPINE; SIGNAL PEPTIDE; THIOL OXIDASE; THIOREDOXIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CELL DEATH; CELL NUCLEUS MEMBRANE; CHROMOSOME 9Q; CONTROLLED STUDY; EXON; GENE IDENTIFICATION; GENE MAPPING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; KNOCKOUT GENE; NEUROBLASTOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMA; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SENSITIZATION; SEQUENCE HOMOLOGY; YEAST;

AMINO ACID SEQUENCE; APOPTOSIS; BASE SEQUENCE; CELL MEMBRANE; CHROMOSOMES, HUMAN, PAIR 9; DNA, ANTISENSE; DNA, COMPLEMENTARY; EXONS; HUMANS; INTERFERON TYPE II; MOLECULAR SEQUENCE DATA; NEUROBLASTOMA; OXIDOREDUCTASES; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION;

EID: 0344412941     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Kaneko, Y., and Cohn, S. L. Ploidy and cytogenetics of neuroblastoma. In: G. M. Brodeur, T. Sawada, Y. Tsuchida, and P. A. Voute (eds.), Neuroblastoma, pp. 41-56. Amsterdam: Elsevier, 2000.
2. Ambros, P. F., and Brodeur, G. M. Concept of tumorigenesis and regression. In: G. M. Brodeur, T. Sawada, Y. Tsuchida, and P. A. Voute (eds.), Neuroblastoma, pp, 21-32, Amsterdam: Elsevier, 2000.
3. Nakagawara, A. Molecular basis of spontaneous regression of neuroblastoma: role of neurotrophic signals and genetic abnormalities. Hum Cell., 11: 115-124, 1998.
4. Hamburger, V. History of the discovery of neuronal death in embryos. J. Neurobiol., 23: 1116-1123, 1992.
5. Ikeda, H., and Castle, V. P. Apoptosis in neuroblastoma and pathways involving Bcl-2 and caspases. In: G.M. Brodeur, T. Sawada, Y. Tsuchida, and P. A. Voute (eds.), Neuroblastoma, pp. 197-206. Amsterdam: Elsevier, 2000.
6. Ikeda, H., Hirato, J., Akami, M., Suzuki, N., Takahashi, A., Kuroiwa, M., and Matsuyama, S. Massive apoptosis detected by in situ DNA nick end labeling in neuroblastoma. Am. J. Surg. Pathol., 20: 649-655, 1996.
7. Hopkins-Donaldson, S., Bodmer, J. L., Bourloud, K. B., Brognara, C. B., Tschopp, J., and Gross, N. Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res., 60: 4315-4319, 2000.
8. Nakagawara, A., Nakamura, Y., Ikeda, H., Hiwasa, T., Kuida, K., Su, M. S., Zhao, H., Cnaan, A., and Sakiyama, S. High levels of expression and nuclear localization of interleukin-1β converting enzyme (ICE) and CPP32 in favorable human neuroblastomas. Cancer Res., 57: 4578-4584, 1997.
9. Fulda, S., Sieverts, H., Friesen, C., Herr, I., and Debatin, K. M. The CD95 (APO-I/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res., 57: 3823-3829, 1997.
10. Behrens, M. M., Martinez, J. L., Moratilla, C., and Renart, J. Apoptosis induced by protein kinase C inhibition in a neuroblastoma cell line. Cell Growth Differ., 6: 1375-1380, 1995.
11. Wittke, I., Madge, B., Wiedemeyer, R., Kimchi, A., and Schwab, M. DAP-5 is involved in MycN/IFNγ-induced apoptosis in human neuroblastoma cells. Cancer Lett., 162: 237-243, 2001.
12. Lutz, W., Fulda, S., Jeremias, I., Debatin, K. M., and Schwab, M. MycN and IFNγ cooperate in apoptosis of human neuroblastoma cells. Oncogene. 17: 339-346, 1998.
13. Fulda, S., Lutz, W., Schwab, M., and Debatin, K. M. MycN sensitizes neuroblastoma cells for drug-induced apoptosis. Oncogene, 18: 1479-1486, 1999.
14. Deiss, L. P., and Kimchi, A. A genetic tool used to identify thioredoxin as a mediator of a growth inhibitory signal. Science (Wash. DC), 252: 117-120, 1991.
15. Hoober, K. L., Joneja, B., White, H. B., III, and Thorpe, C. A sulfhydryl oxidase from chicken egg white. J. Biol. Chem., 271: 30510-30516, 1996.
16. Ostrowski, M. C., and Kistler, W. S. Properties of a flavoprotein sulfhydryl oxidase from rat seminal vesicle secretion. Biochemistry, 19: 2639-2645, 1980.
17. Hoober, K. L., Sheasley, S. L., Gilbert, H. F., and Thorpe, C. Sulfhydryl oxidase from egg white. A facile catalyst for disulfide bond formation in proteins and peptides. J. Biol. Chem., 274. 22147-22150, 1999.
18. Lisowsky, T. ERV1 is involved in the cell-division cycle and the maintenance of mitochondrial genomes in Saccharomyces cerevisiae. Curr. Genet., 26: 15-20, 1994.
19. Giorda, R., Hagiya, M., Seki, T., Shimonishi, M., Sakai, H., Michaelson, J., Francavilla, A., Starzl, T. E., and Trucco, M. Analysis of the structure and expression of the augmenter of liver regeneration (ALR) gene. Mol. Med., 2: 97-108, 1996.
20. Coppock, D. L., Cina-Poppe, D., and Gilleran, S. The quiescin Q6 gene (QSCN6) is a fusion of two ancient gene families: thioredoxin and ERV1. Genomics, 54: 460-468, 1998.
21. Benayoun, B., Esnard-Feve, A., Castella, S., Courty, Y., and Esnard, F. Rat seminal vesicle FAD-dependent sulfhydryl oxidase. Biochemical characterization and molecular cloning of a member of the new sulfhydryl oxidase/quiescin Q6 gene family, J. Biol. Chem., 276: 13830-13837, 2001.
22. Hashimoto, Y., Suga, Y., Matsuba, S., Mizoguchi, M., Takamori, K., Seitz, J., and Ogawa, H. Inquiry into the role of skin sulfhydryl oxidase in epidermal disulfide bond formation: implications of the localization and regulation of skin SOx as revealed by TPA, retinoic acid, and UVB radiation. J. Investig. Dermatol., 117: 752-754, 2001.
23. Hoober, K. L., Glynn, N. M., Burnside, J., Coppock, D. L., and Thorpe, C. Homology between egg white sulfhydryl oxidase and quiescin Q6 defines a new class of flavin-linked sulfhydryl oxidases. J. Biol. Chem., 274: 31759-31762, 1999.
24. Wiedemeyer, R., Westermann, F., Wittke, I., Nowock, J., and Schwab, M. Ataxin-2 promotes apoptosis of human neuroblastoma cells. Oncogene, 22: 401-411, 2003.
25. Lutz, W., Stohr, M., Schurmann, J., Wenzel, A., Lohr, A., and Schwab, M. Conditional expression of N-myc in human neuroblastoma cells increases expression of α-prothymosin and omithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells. Oncogene, 13: 803-812, 1996.
26. Bannasch, D., Weis, I., and Schwab, M. Nmi protein interacts with regions that differ between MycN and Myc and is localized in the cytoplasm of neuroblastoma cells in contrast to nuclear MycN. Oncogene, 18: 6810-6817, 1999.
27. Hirt, B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol., 26: 365-369, 1967.
28. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., and Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening, J. Natl. Cancer Inst. (Bethesda), 82: 1107-1112, 1990.
29. An, H. X., Claas, A., Savelyeva, L., Seitz, S., Schlag, P., Scherneck, S., and Schwab, M, Two regions of deletion in 9p23-24 in sporadic breast cancer. Cancer Res., 59: 3941-3943, 1999.
30. Savelyeva, L., Claas, A., Gier, S., Schlag, P., Finke, L., Mangion, J., Stratton, M. R., and Schwab, M. An interstitial tandem duplication of 9p23-24 coexists with a mutation in the BRCA2 gene in the germ line of three brothers with breast cancer. Cancer Res., 58: 863-866, 1998.
31. Chersi, A., Ruocco, E., and Muratti, E. Preparation and properties of gel-peptide immunoadsorbents. J. Immunol. Methods, 122: 285-289, 1989.
32. Rehm, H. Der Experimentator: Proteinbiochemie, (Ed. 2), Vol. 2te Auflage, p. 217. Stuttgart, Jena, Lübeck, Ulm: Gustav Fischer Verlag, 1997.
33. Wu, Y., Ozaki, Y., Inoue, K., Satoh, K., Ohmori, T., Yatomi, Y., and Owadab, K. Differential activation and redistribution of c-Src and Fyn in platelets, assessed by MoAb specific for C-terminal tyrosine-dephosphorylated c-Src and Fyn. Biochim. Biophys. Acta, 1497, 27-36, 2000.
34. Thorpe, C., Hoober, K. L., Raje, S., Glynn, N. M., Burnside, J., Turi, G. K., and Coppock, D. L. Sulfhydryl oxidases: emerging catalysts of protein disulfide bond formation in eukaryotes, Arch. Biochem. Biophys. 405: 1-12, 2002.
35. Kozak, M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res., 15: 8125-8148, 1987.
36. Devireddy, L. R., and Jones, C. Alternative splicing of the latency-related transcript of bovine herpesvirus I yields RNAs containing unique open reading frames. J. Virol., 72: 7294-7301, 1998.
37. Gyapay, G., Morissette, J., Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S., Bernardi, G., Lathrop, M., and Weissenbach, J. The 1993-94 Genethon human genetic linkage map. Nat. Genet., 7: 246-339, 1994.
38. Levy-Strumpf, N., and Kimchi, A. Death associated proteins (DAPs): from gene identification to the analysis of their apoptotic and tumor suppressive functions. Oncogene. 17: 3331-3340, 1998.
39. Hofmann, E. R., Boyanapalli, M., Lindner, D. J., Weihua, X., Hassel, B. A., Jagus, R., Gutierrez, P. L., Kalvakolanu, D. V., and Hofman, E. R. Thioredoxin reductase mediates cell death effects of the combination of beta interferon and retinoic acid, Mol. Cell. Biol., 18: 6493-6504, 1998.
40. Lee, J., Hofhaus, G., and Lisowsky, T. Erv1p from Saccharomyces cerevisiae is a FAD-linked sulfhydryl oxidase. FEBS Lett., 477: 62-66, 2000.
41. Gerber, J., Muhlenhoff, U., Hofhaus, G., Lill, R., and Lisowsky, T. Yeast ERV2p is the first microsomal FAD-linked sulfhydryl oxidase of the Erv1p/A1rp protein family. J. Biol. Chem., 276: 23486-23491, 2001.
42. Lisowsky, T., Lee, J. E., Polimeno, L., Francavilla, A., and Hofhaus, G. Mammalian augmenter of liver regeneration protein is a sulfhydryl oxidase. Dig. Liver Dis., 33: 173-180, 2001.
43. Senkevich, T. G., White, C. L., Koonin, E. V., and Moss, B. A viral member of the ERV1/ALR protein family participates in a cytoplasmic pathway of disulfide bond formation. Proc. Natl. Acad. Sci. USA, 97: 12068-12073, 2000.
44. Coppock, D., Kopman, C., Gudas, J., and Cina-Poppe, D. A. Regulation of the quiescence-induced genes: quiescin Q6, decorin, and ribosomal protein S29. Biochem. Biophys. Res. Commun., 269: 604-610, 2000.
45. Takita, J., Hayashi, Y., Kohno, T., Yamaguchi, N., Hanada, R., Yamamoto, K., and Yokota, J. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma. Cancer Res., 57: 907-912, 1997.
46. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., and Hancock, D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69: 119-128, 1992.
47. Gallegos, A., Gasdaska, J. R., Taylor, C. W., Paine-Murrieta, G. D., Goodman, D., Gasdaska, P. Y., Berggren, M., Briehl, M. M., and Powis G. Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells. Cancer Res., 56: 5765-5770, 1996.
48. Mau, B. L., and Powis, G. Inhibition of cellular thioredoxin reductase by diaziquone and doxorubicin. Relationship to the inhibition of cell proliferation and decreased ribonucleotide reductase activity. Biochem. Pharmacol., 43: 1621-1627, 1992.
49. Berggren, M., Gallegos, A., Gasdaska, J. R., Gasdaska, P. Y., Warneke, J., and Powis, G. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia. Anticancer Res., 16: 3459-3466, 1996.
50. Ma, X., Karra, S., Lindner, D. J., Hu, J., Reddy, S. P., Kimchi, A., Yodoi, J., and Kalvakolanu, D. D. Thioredoxen participates in a cell death pathway induced by interferon and retinoid combination. Oncogene. 20: 3703-3715, 2001.
51. Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., and Vogelstein, B. A model for p53-induced apoptosis, Nature (Lond.), 389: 300-305, 1997.
52. Hu, J., Ma, X., Lindner, D. J., Karra, S., Hofmann, E. R., Reddy, S. P., and Kalvakolanu, D. V. Modulation of p53-dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the interferon-retinoid combination. Oncogene, 20: 4235-4248, 2001.
53. Hainaut, P., and Milner, J. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res., 53: 4469-4473, 1993.
54. Schenk, H., Klein, M., Erdbrugger, W., Droge, W., and Schulze-Osthoff, K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc. Natl. Acad. Sci. USA, 91: 1672-1676, 1994.
55. Arner, E. S., and Holmgren, A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem., 267: 6102-6109, 2000.
56. Sevier, C. S., Cuozzo, J. W., Vala, A., Aslund, F., and Kaiser, C. A. A flavoprotein oxidase defines a new endoplasmic reticulum pathway for biosynthetic disulphide bond formation. Nat. Cell Biol., 3: 874-882, 2001.
57. Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., and Ichijo, H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J., 17: 2596-2606, 1998.
58. Arner, E. S., Zhong, L., and Holmgren, A. Preparation and assay of mammalian thioredoxin and thioredoxin reductase. Methods Enzymol., 300: 226-239, 1999.
59. Bennett, M., Macdonald, K., Chan, S. W., Luzio, J. P., Simari, R., and Weissberg, P. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science (Wash. DC), 282: 290-293, 1998.